The Impact of COVID-19 on Migraine: The Patients’ Perspective
The COVID-19 pandemic represents a global health phenomenon that will sadly remain part of our history. It had innumerable consequences for society and people’s lives. With different mechanisms, COVID-19 has been pointed out as a factor in the pathophysiology of several secondary disorders or the de...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Life |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-1729/14/11/1420 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850266594876325888 |
|---|---|
| author | Angelo Torrente Paolo Alonge Roberta Baschi Laura Pilati Vincenzo Di Stefano Cecilia Camarda Filippo Brighina Roberto Monastero |
| author_facet | Angelo Torrente Paolo Alonge Roberta Baschi Laura Pilati Vincenzo Di Stefano Cecilia Camarda Filippo Brighina Roberto Monastero |
| author_sort | Angelo Torrente |
| collection | DOAJ |
| description | The COVID-19 pandemic represents a global health phenomenon that will sadly remain part of our history. It had innumerable consequences for society and people’s lives. With different mechanisms, COVID-19 has been pointed out as a factor in the pathophysiology of several secondary disorders or the deterioration of pre-existing conditions. Migraine is a frequent disorder that can be influenced by several conditions, including psychologically stressful conditions or infectious diseases. The purpose of the present study is to gain insight into the influence of COVID-19 on the clinical characteristics of patients with migraine. A self-administrable questionnaire has been developed, asking for migraine features before and after COVID-19 infection. One hundred and two patients who had been infected at least once were included. After COVID-19 infection, 54 reported the worsening of migraine, 45 noticed no variation, and 3 reported an improvement. After the infection, 21 patients changed preventive therapy due to the loss of efficacy of the previous one. The most effective treatments in this subpopulation were gene-related peptide monoclonal antibodies. The presented data confirm that the influence of COVID-19 is heterogeneous in patients with migraine, but new treatments may be effective in controlling the symptoms among those who report a worsening of the disease. |
| format | Article |
| id | doaj-art-33b4dc053ebb4782a0b0df19875d5a6a |
| institution | OA Journals |
| issn | 2075-1729 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Life |
| spelling | doaj-art-33b4dc053ebb4782a0b0df19875d5a6a2025-08-20T01:54:07ZengMDPI AGLife2075-17292024-11-011411142010.3390/life14111420The Impact of COVID-19 on Migraine: The Patients’ PerspectiveAngelo Torrente0Paolo Alonge1Roberta Baschi2Laura Pilati3Vincenzo Di Stefano4Cecilia Camarda5Filippo Brighina6Roberto Monastero7Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND.), University of Palermo, 90127 Palermo, ItalyDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BIND.), University of Palermo, 90127 Palermo, ItalyDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BIND.), University of Palermo, 90127 Palermo, ItalyDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BIND.), University of Palermo, 90127 Palermo, ItalyDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BIND.), University of Palermo, 90127 Palermo, ItalyDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BIND.), University of Palermo, 90127 Palermo, ItalyDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BIND.), University of Palermo, 90127 Palermo, ItalyDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BIND.), University of Palermo, 90127 Palermo, ItalyThe COVID-19 pandemic represents a global health phenomenon that will sadly remain part of our history. It had innumerable consequences for society and people’s lives. With different mechanisms, COVID-19 has been pointed out as a factor in the pathophysiology of several secondary disorders or the deterioration of pre-existing conditions. Migraine is a frequent disorder that can be influenced by several conditions, including psychologically stressful conditions or infectious diseases. The purpose of the present study is to gain insight into the influence of COVID-19 on the clinical characteristics of patients with migraine. A self-administrable questionnaire has been developed, asking for migraine features before and after COVID-19 infection. One hundred and two patients who had been infected at least once were included. After COVID-19 infection, 54 reported the worsening of migraine, 45 noticed no variation, and 3 reported an improvement. After the infection, 21 patients changed preventive therapy due to the loss of efficacy of the previous one. The most effective treatments in this subpopulation were gene-related peptide monoclonal antibodies. The presented data confirm that the influence of COVID-19 is heterogeneous in patients with migraine, but new treatments may be effective in controlling the symptoms among those who report a worsening of the disease.https://www.mdpi.com/2075-1729/14/11/1420COVID-19pandemicmigraineCGRPpatient’s reportpatient’s point of view |
| spellingShingle | Angelo Torrente Paolo Alonge Roberta Baschi Laura Pilati Vincenzo Di Stefano Cecilia Camarda Filippo Brighina Roberto Monastero The Impact of COVID-19 on Migraine: The Patients’ Perspective Life COVID-19 pandemic migraine CGRP patient’s report patient’s point of view |
| title | The Impact of COVID-19 on Migraine: The Patients’ Perspective |
| title_full | The Impact of COVID-19 on Migraine: The Patients’ Perspective |
| title_fullStr | The Impact of COVID-19 on Migraine: The Patients’ Perspective |
| title_full_unstemmed | The Impact of COVID-19 on Migraine: The Patients’ Perspective |
| title_short | The Impact of COVID-19 on Migraine: The Patients’ Perspective |
| title_sort | impact of covid 19 on migraine the patients perspective |
| topic | COVID-19 pandemic migraine CGRP patient’s report patient’s point of view |
| url | https://www.mdpi.com/2075-1729/14/11/1420 |
| work_keys_str_mv | AT angelotorrente theimpactofcovid19onmigrainethepatientsperspective AT paoloalonge theimpactofcovid19onmigrainethepatientsperspective AT robertabaschi theimpactofcovid19onmigrainethepatientsperspective AT laurapilati theimpactofcovid19onmigrainethepatientsperspective AT vincenzodistefano theimpactofcovid19onmigrainethepatientsperspective AT ceciliacamarda theimpactofcovid19onmigrainethepatientsperspective AT filippobrighina theimpactofcovid19onmigrainethepatientsperspective AT robertomonastero theimpactofcovid19onmigrainethepatientsperspective AT angelotorrente impactofcovid19onmigrainethepatientsperspective AT paoloalonge impactofcovid19onmigrainethepatientsperspective AT robertabaschi impactofcovid19onmigrainethepatientsperspective AT laurapilati impactofcovid19onmigrainethepatientsperspective AT vincenzodistefano impactofcovid19onmigrainethepatientsperspective AT ceciliacamarda impactofcovid19onmigrainethepatientsperspective AT filippobrighina impactofcovid19onmigrainethepatientsperspective AT robertomonastero impactofcovid19onmigrainethepatientsperspective |